Role of epidermal growth factor receptor overexpression, K-ras point mutation and c-myc amplification in the carcinogenesis of non-small cell lung cancer

Oncology Reports

Volumn 5, Issue 2, 1998, Pages 351-354

  Sekine, Ikuo ^a   Takami, Satoshi ^b   Guang, Shao Guo ^c   Yokose, Tomoyuki ^c   Kodama, Tetsuro ^a   Nishiwaki, Yutaka ^a   Kinoshita, Moritoshi ^b   Matsumoto, Hisanori ^b   Ogura, Tsutomu ^c   Nagai, Kanji ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b OTSUKA PHARMACEUTICAL CO LTD   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

C myc; Epidermal growth factor receptor; K ras; Lung cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; RAS PROTEIN;

ADULT; AGED; ARTICLE; DISEASE ASSOCIATION; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; ONCOGENE C MYC; ONCOGENE K RAS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY;

EID: 13144257716     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.5.2.351     Document Type: Article

References (31)

1. Kastan MB: Molecular biology of cancer: The cell cycle. In: Cancer Principles & Practice of Oncology. Devita VT, Hellman S and Rosenberg SA (eds.) 5th edition, Lippincott-Raven Publishers, Philadelphia, pp121-134, 1997.
2. Ullrich A and Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990.
3. Aaronson SA: Growth factors and cancer. Science 254: 1146-1153, 1991.
4. De Vries JE, ten Kate J and Bosman FT: p21 ras in carcinogenesis. Pathol Res Pract 192: 658-668, 1996.
5. Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J and Waterfield MD: Close similarity of epidermal growth factor receptor and v-ere-B oncogene protein sequences. Nature 307: 521-527, 1984.
6. Akiyama T, Sudo C, Ogawara H, Toyoshima K and Yamamoto T: The product of the human c-erbB-2 gene: A 185-kilodalton glycoprotein with tyrosine kinase activity. Science 232: 1644-1646, 1986.
7. Ryan RM and Finkelstein JN: Growth factors and pulmonary epithelia. In: Signal Transduction in Lung Cells. Brody JS, Center DM and Tkachuk VA (eds.) Marcel Dekker Inc., New York, pp263-291, 1993.
8. Dittadi R, Gion M, Pagan V, Brazzale A, Del Maschio O, Bargossi A, Busetto A and Bruscagnin G: Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. Er J Cancer 64: 741-744, 1991.
9. Rusch V, Baselga J, Cordon-Cardo C, Orazem J, Zaman M, Hoda S, McIntosh J, Kurie J and Dmitrovsky E: Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung. Cancer Res 53: 2379-2385, 1993.
10. Keohavong P, DeMichele MAA, Melacrinos AC, Landreneau RJ, Weyant RJ and Siegfried JM: Detection of K-ras mutations in lung carcinomas: relationship to prognosis. Clin Cancer Res 2: 411-418, 1996.
11. Suzuki Y, Orita M, Shiraishi M, Hayashi K and Sekiya T: Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene 5: 1037-1043, 1990.
12. Lung ML, Wong M, Lam WK, Lau KS, Kwan S, Fu K, Cheung H and Yew WW: Incidence of ras oncogene activation in lung carcinomas in Hong Kong. Cancer 70: 760-763, 1992.
13. Rodenhuis S and Slebos RJC: Clinical significance of ras oncosene activation in human lung cancer. Cancer Res 52 (Suppl): 2665s-2669s, 1992.
14. Liboi E, Pelosi E, Testa U, Peschle C and Rossi GB. Proliferative response and oncogene expression induced by epidermal growth factor in EL2 rat fibroblasts. Mol Cell Biol 6: 2275-2278, 1986.
15. Cutry AF, Kinniburgh AJ, Krabak MJ, Hui S-W and Wenner CE: Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor alpha is calcium-independent. J Biol Chem 264: 19700-19705, 1989.
16. Balk SD, Riley TM. Gunther HS and Morisi A: Heparin-treated, v-myc-transformed chicken heart mesenchymal cells assume a normal morphology but are hypersensitive to epidermal growth factor (EGF) and brain fibroblast growth factor (bFGF); cells transformed by the v-Ha-ras oncogene are refractory to EGF and bFGF but are hypersensitive to insulin-like growth factors. Proc Natl Acad Sci USA 82: 5781-5785, 1985.
17. Stern DF, Roberts AB, Roche NS. Sporn MB and Weinberg RA: Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal srowth factor. Mol Cell Biol 6: 870-877, 1986.
18. Fitzpatrick SL, Brightwell J, Wittliff JL, Barrows GH and Schultz GS: Epidermal growth factor binding by breast tumor biopsies and relationship to estrogen receptor and progestin receptor. Cancer Res 44: 3448-3453, 1984.
19. Parker CW: Radiolabeling of proteins. Methods Enzymol 182: 721-737, 1990.
20. Shao GG, Ogura T, Sekine I, Yokozaki M, Esumi H, Kodama T and Nagai K: Association between p53 mutation and clinicopathological features of non-small cell lung cancer. Jpn J Clin Oncol 27: 211-215, 1997.
21. Kinoshita M, Katsuragi K, Shin S and Aono T: Amplification and point-mutation alterations of oncogenes in patients with cervical cancer-associated human papillomavirus. Biomed Res 14: 403-410, 1993.
22. Burghuber OC, Worofka B, Schernthaner G, Vetter N, Neumann M, Dudczak R and Kuzmits R: Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Cancer 65: 1386-1390, 1990.
23. Veale D, Kerr N, Gibson GJ and Haris AL: Characterization of epidermal growth factor receptor in primary human non-small cell lung cancer. Cancer Res 49: 1313-1317, 1989.
24. Fontanini G, Vignati S, Bigini D, Mussi A, Lucchi H, Angeletti CA, Pingitore R, Pepe S, Basolo F and Bevilacqua G: Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer 31 A: 178-183, 1995.
25. Berger MS, Gullick WJ, Greenfield C, Evans S. Addis BJ and Waterfield MD: Epidermal growth factor receptors in lung tumors. J Pathol 152: 297-307, 1987.
26. Green MR and Couchman JR: Difference in human skin between epidermal growth factor receptor distribution detected by EGF binding and monoclonal antibody recognition. J Invest Dermatol 85: 239-245, 1985.
27. Sugio K, Ishida T, Yokoyama H, Inoue T, Sugimachi K and Sasazuki T: Ras gene mutations as a prognostic marker in adenocarcinoma of the human lung without lymph node metastasis. Cancer Res 52: 2903-2906, 1992.
28. Johnson BE: The role of MYC, JUN and FOS oncogenes in human lung cancer. In: Lung Cancer: Principles & Practice. Pass HI, Mitchell JB, Johnson DH and Turrisi AT (eds.) Lippincott-Raven Publishers, Philadelphia, pp83-98, 1996.
29. Gotoh N, Toyoda M and Shibuya M: Tyrosine phosphorylation sites at amino acids 239 and 240 of She are involved in epidermal growth factor-induced mitogenic signaling that is distinct from ras/mitogen-activated protein kinase activation. Mol Cell Biol 17: 1824-1831, 1997.
30. Satoh T, Endo M, Nakafuku M, Akiyama T. Yamamoto T and Kaziro Y: Accumulation of p21 ras GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity. Proc Natl Acad Sci USA 87: 7926-7929, 1990.
31. Salomon DS, Perroteau I, Kidwell WR, Tam J and Derynck R: Loss of growth responsiveness to epidermal growth factor and enhanced production of alpha-transforming growth factors in ras-transformed mouse mammary epithelial cells. J Cell Physiol 130: 397-409, 1987.